Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan/Hydrochlorothiazide vs Irbesartan in Mild to Moderate Hypertension
NCT00263003Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan + hydrochlorothiazide in hypertension (HTN), sponsored by Sanofi. Started Jun 2005; status: completed.
02
Drugs
irbesartan + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00263003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263003.